REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 106 filers reported holding REPLIMUNE GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $272,382 | -47.7% | 32,311 | +6.1% | 0.05% | -53.2% |
| Q3 2023 | $521,290 | -12.9% | 30,467 | +18.2% | 0.11% | -7.5% |
| Q2 2023 | $598,333 | +44.6% | 25,768 | +10.0% | 0.12% | +0.8% |
| Q1 2023 | $413,809 | -43.8% | 23,432 | -13.4% | 0.12% | -83.3% |
| Q4 2022 | $736,059 | +54.3% | 27,061 | -2.1% | 0.71% | +63.0% |
| Q3 2022 | $477,000 | -11.2% | 27,644 | -9.9% | 0.44% | +7.1% |
| Q2 2022 | $537,000 | +4.9% | 30,695 | +1.7% | 0.41% | +69.7% |
| Q1 2022 | $512,000 | -49.1% | 30,182 | -18.7% | 0.24% | -34.2% |
| Q4 2021 | $1,006,000 | – | 37,105 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
| Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
| Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
| GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
| Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
| Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
| Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |